Mesa

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• COPD1 trial
• Liver cirrhosis1 trial
• Lupus (SLE)1 trial
• Ovarian cancer1 trial

Phase

• Phase 23 trials
• Phase 31 trial
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• GlaxoSmithKline4 trials
• Tesaro, Inc.1 trial

Running trials

• Recruiting

  A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  NCT06920043· Phase 2· GlaxoSmithKline· Source

  Contact: Ann Moore (principal investigator)

• Active, not recruiting

  A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

  NCT06411249· Phase 4· GlaxoSmithKline· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting
• Liver cirrhosis1 recruiting

Closed trials

• Completed

  Phase 2b Study of GSK4532990 in Adults With NASH

  NCT05583344· Phase 2· GlaxoSmithKline· Source

• Completed

  Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

  NCT04133909· Phase 3· GlaxoSmithKline· Source

• Completed

  A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

  NCT03326193· Phase 2· Tesaro, Inc.· Source